Mindfulness during dialysis plus pre-dialysis strength training for sarcopenia in dialysis patients
Official title: A Study on the Clinical Efficacy and Safety Evaluation of Mindfulness Meditation During Dialysis Combined With Pre-Dialysis Progressive Resistance Training for Hemodialysis Patients With Sarcopenia
Run by Ningbo Medical Center Lihuili Hospital · NCT07724587 · Data updated 2026-11-12
This study tests whether adding mindfulness meditation during dialysis to pre-dialysis resistance training helps improve muscle mass and safety in adults undergoing maintenance hemodialysis with sarcopenia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 76 (estimated) |
| Sponsor | Ningbo Medical Center Lihuili Hospital Government |
| Locations | 1 site (Ningbo) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07724587 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults on regular hemodialysis (3 times/week) for at least 3 months with sarcopenia who can participate in supervised exercise.
✕Probably not a fit
Patients unable to participate in supervised exercise or mindfulness training, or those with recent major cardiovascular events or cognitive impairment, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized trial, 76 maintenance hemodialysis patients with sarcopenia are assigned to three groups: a control group receiving standard care, a sports group doing pre-dialysis resistance training, and an intervention group that adds mindfulness meditation during dialysis. Outcomes including muscle mass via ultrasound, sleep quality, anxiety, and depression are assessed at baseline and 12 weeks, with blinded assessors to reduce bias. The program follows a four-part protocol: assessment and education, one-repetition maximum testing, pre-dialysis resistance training, and mindfulness training during dialysis. The study design aims to determine if the combined intervention is safe and more effective than exercise or standard care alone.
Why it matters
Potential benefit: If successful, patients may experience better muscle mass and well-being with a feasible, non-pharmacologic approach.
How similar studies have gone: Previous evidence supports exercise-based approaches for sarcopenia in dialysis patients; adding mindfulness is exploratory and less established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meet the updated Asian diagnostic criteria for sarcopenia * Stable vital signs and general physical condition * Willing and able to cooperate with supervised exercise training * Regular hemodialysis 3 times per week for at least 3 months Exclusion Criteria: * Acute cardiovascular or cerebrovascular events within the previous 3 months * Cognitive dysfunction affecting study cooperation and exercise completion * Severe osteoarticular or limb movement disorders preventing standardized exercise training * Active systemic infection
Where it's running
-
Yongyao Wu
Ningbo, China Recruiting
Study contacts
- Principal investigator: yongyao wu — Department of Nephrology, Ningbo Medical Center Li Huili Hospital
- Study coordinator: yongyao wu
- Email: wuyongyao.12345@163.com
- Phone: 8615967857855
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.